Aliada is developing a platform to improve drug delivery to the brain for multiple modalities including, monoclonal antibodies, enzymes, and oligonucleotides
Investors 1
| Date | Name | Website |
| 30.08.2023 | OrbiMed | orbimed.co... |
Mentions in press and media 1
| Date | Title | Description | Source |
| - | Aliada Therapeutics | “Aliada Therapeutics” | fastfounde... |